This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Diabetic Retinopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

The Eye Diseases Prevalence Research Group^*

Arch Ophthalmol. 2004;122:552-563.

Objective  To determine the prevalence of diabetic retinopathy among adults 40 years and older in the United States.

Methods  Pooled analysis of data from 8 population-based eye surveys was used to estimate the prevalence, among persons with diabetes mellitus (DM), of retinopathy and of vision-threatening retinopathy—defined as proliferative or severe nonproliferative retinopathy and/or macular edema. Within strata of age, race/ethnicity, and gender, US prevalence rates were estimated by multiplying these values by the prevalence of DM reported in the 1999 National Health Interview Survey and the 2000 US Census population.

Results  Among an estimated 10.2 million US adults 40 years and older known to have DM, the estimated crude prevalence rates for retinopathy and vision-threatening retinopathy were 40.3% and 8.2%, respectively. The estimated US general population prevalence rates for retinopathy and vision-threatening retinopathy were 3.4% (4.1 million persons) and 0.75% (899 000 persons). Future projections suggest that diabetic retinopathy will increase as a public health problem, both with aging of the US population and increasing age-specific prevalence of DM over time.

Conclusion  Approximately 4.1 million US adults 40 years and older have diabetic retinopathy; 1 of every 12 persons with DM in this age group has advanced, vision-threatening retinopathy.

^*The Writing Committee members for the Eye Diseases Prevalence Research Group who had complete access to the raw data needed for this report and who bear authorship responsibility for this report are John H. Kempen, MD, PhD (chairperson); Benita J. O'Colmain, MPH; M. Cristina Leske, MD, MPH; Steven M. Haffner, MD; Ronald Klein, MD, MPH; Scot E. Moss, MA; Hugh R. Taylor, AC, MD; Richard F. Hamman, MD, DrPH; Sheila K. West, PhD; Jie Jin Wang, MMed, MApplStat, PhD; Nathan G. Congdon, MD, MPH; and David S. Friedman, MD, MPH. The Writing Group for this article has no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Abnormal Retinal Vascular Oxygen Tension Response to Light Flicker in Diabetic Rats
Blair et al.
IOVS 2009;50:5444-5448.
ABSTRACT | FULL TEXT  

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy
Gonzalez et al.
Br J Ophthalmol 2009;93:1474-1478.
ABSTRACT | FULL TEXT  

Influence of Dosage Form on the Intravitreal Pharmacokinetics of Diclofenac
Durairaj et al.
IOVS 2009;50:4887-4897.
ABSTRACT | FULL TEXT  

A Systematic Meta-Analysis of Genetic Association Studies for Diabetic Retinopathy
Abhary et al.
Diabetes 2009;58:2137-2147.
ABSTRACT | FULL TEXT  

Comparative Evaluation of Apoptotic Activity in Photoreceptor Cells after Intravitreal Injection of Bevacizumab and Pegaptanib Sodium in Rabbits
Avci et al.
IOVS 2009;50:3438-3446.
ABSTRACT | FULL TEXT  

Higher Prevalence of Retinopathy in Diabetic Patients of South Asian Ethnicity Compared With White Europeans in the Community: A cross-sectional study
Raymond et al.
Diabetes Care 2009;32:410-415.
ABSTRACT | FULL TEXT  

Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-standing Diabetic Macular Edema
Davis et al.
IOVS 2009;50:1-4.
ABSTRACT | FULL TEXT  

Projection of Diabetic Retinopathy and Other Major Eye Diseases Among People With Diabetes Mellitus: United States, 2005-2050
Saaddine et al.
Arch Ophthalmol 2008;126:1740-1747.
ABSTRACT | FULL TEXT  

Resource Use and Costs Associated With Diabetic Macular Edema in Elderly Persons
Shea et al.
Arch Ophthalmol 2008;126:1748-1754.
ABSTRACT | FULL TEXT  

Changes in Incidence of Diabetes Mellitus-Related Eye Disease Among US Elderly Persons, 1994-2005
Sloan et al.
Arch Ophthalmol 2008;126:1548-1553.
ABSTRACT | FULL TEXT  

Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
Cade
ptjournal 2008;88:1322-1335.
ABSTRACT | FULL TEXT  

Diabetes Mellitus and Visual Impairment: National Health and Nutrition Examination Survey, 1999-2004
Zhang et al.
Arch Ophthalmol 2008;126:1421-1427.
ABSTRACT | FULL TEXT  

Heritability of the Severity of Diabetic Retinopathy: The FIND-Eye Study
Arar et al.
IOVS 2008;49:3839-3845.
ABSTRACT | FULL TEXT  

Does Functional Vision Behave Differently in Low-Vision Patients with Diabetic Retinopathy?--A Case-Matched Study
Ahmadian and Massof
IOVS 2008;49:4051-4057.
ABSTRACT | FULL TEXT  

Retinal Vascular Lesions in Patients of Caucasian and Asian Origin With Type 2 Diabetes: Baseline results from the ADVANCE Retinal Measurements (AdRem) study
Stolk et al.
Diabetes Care 2008;31:708-713.
ABSTRACT | FULL TEXT  

Retinal Signs and Stroke: Revisiting the Link Between the Eye and Brain
Baker et al.
Stroke 2008;39:1371-1379.
ABSTRACT | FULL TEXT  

Self-Reported Age-Related Eye Diseases and Visual Impairment in the United States: Results of the 2002 National Health Interview Survey
Ryskulova et al.
AJPH 2008;98:454-461.
ABSTRACT | FULL TEXT  

Introduction
Ryan
Am J Health Syst Pharm 2007;64:S2-S2.
FULL TEXT  

Etiology and natural history of diabetic retinopathy: An overview
Morello
Am J Health Syst Pharm 2007;64:S3-S7.
ABSTRACT | FULL TEXT  

Association of Statin Use With the Risk of Developing Diabetic Retinopathy
Zhang and McGwin
Arch Ophthalmol 2007;125:1096-1099.
ABSTRACT | FULL TEXT  

Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease
Tuttle et al.
CJASN 2007;2:631-636.
ABSTRACT | FULL TEXT  

Knowledge, Attitudes, and Beliefs about Dilated Eye Examinations among African-Americans
Ellish et al.
IOVS 2007;48:1989-1994.
ABSTRACT | FULL TEXT  

Genome-Wide Linkage Analyses to Identify Loci for Diabetic Retinopathy
Looker et al.
Diabetes 2007;56:1160-1166.
ABSTRACT | FULL TEXT  

Improving Diabetic Retinopathy Screening Ratios Using Telemedicine-Based Digital Retinal Imaging Technology: The Vine Hill Study
Taylor et al.
Diabetes Care 2007;30:574-578.
ABSTRACT | FULL TEXT  

Eye Care in the United States: Do We Deliver to High-Risk People Who Can Benefit Most From It?
Zhang et al.
Arch Ophthalmol 2007;125:411-418.
ABSTRACT | FULL TEXT  

Retinal Dysfunction in Diabetic Ren-2 Rats Is Ameliorated by Treatment with Valsartan but Not Atenolol
Phipps et al.
IOVS 2007;48:927-934.
ABSTRACT | FULL TEXT  

The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy
Ahmed et al.
Diabetes Care 2006;29:2205-2209.
ABSTRACT | FULL TEXT  

The epidemiology of age related eye diseases in Asia.
Wong et al.
Br J Ophthalmol 2006;90:506-511.
ABSTRACT | FULL TEXT  

Serum Inflammatory Markers in Diabetic Retinopathy
Meleth et al.
IOVS 2005;46:4295-4301.
ABSTRACT | FULL TEXT  

Ruboxistaurin, a Protein Kinase C {beta} Inhibitor, as an Emerging Treatment for Diabetes Microvascular Complications
Joy et al.
The Annals of Pharmacotherapy 2005;39:1693-1699.
ABSTRACT | FULL TEXT  

Ethnicity, Race, and Baseline Retinopathy Correlates in the Veterans Affairs Diabetes Trial
Emanuele et al.
Diabetes Care 2005;28:1954-1958.
ABSTRACT | FULL TEXT  

Prevalence of Diabetic Retinopathy in Urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study, I
Rema et al.
IOVS 2005;46:2328-2333.
ABSTRACT | FULL TEXT  

The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C {beta} Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial
The PKC-DRS Study Group
Diabetes 2005;54:2188-2197.
ABSTRACT | FULL TEXT  

Inhibitors of Ocular Neovascularization: Promises and Potential Problems
van Wijngaarden et al.
JAMA 2005;293:1509-1513.
FULL TEXT  

The Prevalence of Diabetic Retinopathy Among Adult Type 1 Diabetic Persons in the United States
Roy et al.
Arch Ophthalmol 2004;122:546-551.
ABSTRACT | FULL TEXT